Armata Pharmaceuticals (ARMP) Cash from Operations Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 74.39% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 3.23% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 158.60% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 23.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.72% |
| Dec 31, 2025 | 15.81% |
| Sep 30, 2025 | 51.51% |
| Jun 30, 2025 | 29.14% |
| Mar 31, 2025 | 28.38% |
| Dec 31, 2024 | 2.21% |
| Sep 30, 2024 | 8.51% |
| Jun 30, 2024 | 15.61% |
| Mar 31, 2024 | 39.76% |
| Dec 31, 2023 | 22.69% |
| Sep 30, 2023 | 6.25% |
| Jun 30, 2023 | -48.01% |
| Mar 31, 2023 | -399.86% |
| Dec 31, 2022 | -21.95% |
| Sep 30, 2022 | -108.16% |
| Jun 30, 2022 | -79.55% |
| Mar 31, 2022 | 35.80% |
| Dec 31, 2021 | -36.43% |
| Sep 30, 2021 | -27.94% |
| Jun 30, 2021 | -17.69% |
| Mar 31, 2021 | -29.37% |
| Dec 31, 2020 | -130.93% |
| Sep 30, 2020 | 15.04% |
| Jun 30, 2020 | 33.83% |
| Mar 31, 2020 | -72.10% |
| Dec 31, 2019 | 14.59% |
| Sep 30, 2019 | -126.09% |
| Jun 30, 2019 | -210.61% |
| Mar 31, 2019 | 30.46% |
| Dec 31, 2018 | -34.87% |
| Sep 30, 2018 | -240.64% |
| Jun 30, 2018 | 35.99% |
| Mar 31, 2018 | -7.18% |
| Dec 31, 2017 | -58.14% |
| Sep 30, 2017 | 81.06% |
| Jun 30, 2017 | -1.35% |
| Mar 31, 2017 | -6.94% |
| Dec 31, 2016 | 35.35% |
| Sep 30, 2016 | -25.39% |
| Jun 30, 2016 | -8.64% |